
World's First! Fudan Eye & ENT Hospital Team Treats Advanced INI1-Deficient Head and Neck Tumor with CAR-T
The team completed the world's first Trop2-targeted CAR-T therapy for advanced INI1-deficient sinonasal malignant tumor in collaboration with an enterprise. The patient remained stable over 245 days post-infusion with significant tumor shrinkage, showing new potential for solid tumor treatment.
Eye & ENT Hospital of Fudan University



